|
|
本帖最后由 13366149259 于 2020-5-27 16:42 编辑
头大,上一条关于审稿意见的请教,没写完... 对不起,占用公众资源了。
下边是审稿人的意见:
“Further,the computational tools,which is the main discussionhere, including DFT, tools like QSAR, MBO applications… are not discussed atall. Search and USE the reference papers or reviews like the one you put yet:Chem. Rev. 2003, 103, 1793-1873; from Prof. Geerlings, in the introduction, andto refresh, the work of Worth,…: Curr. Med. Chem. 2012, 19, 5219-5225 (DOI:10.2174/092986712803530548); Expert Opin. Drug Deliv. 2010, 7, 295-305 (DOI:10.1517/17425240903508756).” (我将审稿人指出的的参考文献,作为附件一并上传了)
所以请教老师们,我是简单的说该工具的应用呢,还是详细的讨论DFT的理论背景和发展呢?若是后者,我该从哪些方面,简要的介绍呢?
谢谢大家的指导
|
|